INMUNE BIO INC. Earnings Per Share (Basic)
INMUNE BIO INC. (INMB) reported Earnings Per Share (Basic) of -$0.05 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- INMUNE BIO INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.05.
- INMUNE BIO INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.20.
- INMUNE BIO INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.20.
- INMUNE BIO INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.24.
- INMUNE BIO INC. earnings per share, basic for fiscal 2025 was -$1.86.
- INMUNE BIO INC. earnings per share, basic for fiscal 2024 was -$2.11.
- INMUNE BIO INC. earnings per share, basic for fiscal 2023 was -$1.67.
- INMUNE BIO INC. earnings per share, basic for fiscal 2022 was -$1.52.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.05 10-Q · filed 2026-08-06 | -$0.25 10-Q · filed 2026-08-06 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | -$0.20 10-Q · filed 2026-05-07 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.62 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.44 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.42 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.86 10-K · filed 2026-03-30 |
| 2025-09-30 | -$0.24 10-Q · filed 2025-10-30 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.68 10-Q · filed 2025-10-30 | -$2.11 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$1.05 10-Q · filed 2026-08-06 | -$1.49 10-Q · filed 2026-08-06 | -$1.91 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.51 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$0.43 10-Q · filed 2026-05-07 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.43 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.93 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2024-12-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.51 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$2.11 10-K · filed 2026-03-30 |
| 2024-09-30 | -$0.60 10-Q · filed 2025-10-30 | -$1.11 derived: net income ÷ weighted average shares · filed 2025-10-30 | -$1.71 10-Q · filed 2025-10-30 | -$2.18 derived: net income ÷ weighted average shares · filed 2026-04-23 |
| 2024-06-30 | -$0.50 10-Q · filed 2025-08-07 | -$1.11 10-Q · filed 2025-08-07 | -$1.58 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$2.06 derived: net income ÷ weighted average shares · filed 2026-04-23 |
| 2024-03-31 | -$0.61 10-Q · filed 2025-05-08 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.55 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.92 derived: net income ÷ weighted average shares · filed 2026-04-23 |
| 2023-12-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.94 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.30 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.67 10-K · filed 2025-03-27 |
| 2023-09-30 | -$0.48 10-Q · filed 2024-10-31 | -$0.84 derived: net income ÷ weighted average shares · filed 2024-10-31 | -$1.20 10-Q · filed 2024-10-31 | -$1.53 derived: net income ÷ weighted average shares · filed 2024-10-31 |
| 2023-06-30 | -$0.36 10-Q · filed 2024-08-01 | -$0.73 10-Q · filed 2024-08-01 | -$1.05 derived: net income ÷ weighted average shares · filed 2024-10-31 | -$1.48 derived: net income ÷ weighted average shares · filed 2024-10-31 |
| 2023-03-31 | -$0.36 10-Q · filed 2024-05-09 | -$0.69 derived: net income ÷ weighted average shares · filed 2024-10-31 | -$1.12 derived: net income ÷ weighted average shares · filed 2024-10-31 | -$1.50 derived: net income ÷ weighted average shares · filed 2024-10-31 |
| 2022-12-31 | -$0.33 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.76 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.14 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.52 10-K · filed 2024-03-28 |
| 2022-09-30 | -$0.43 10-Q · filed 2023-11-01 | -$0.81 derived: net income ÷ weighted average shares · filed 2023-11-01 | -$1.20 10-Q · filed 2023-11-01 | -$1.74 derived: net income ÷ weighted average shares · filed 2023-11-01 |
| 2022-06-30 | -$0.38 10-Q · filed 2023-08-07 | -$0.77 10-Q · filed 2023-08-07 | -$1.31 derived: net income ÷ weighted average shares · filed 2023-11-01 | -$1.85 derived: net income ÷ weighted average shares · filed 2023-11-01 |
| 2022-03-31 | -$0.39 10-Q · filed 2023-05-03 | -$0.93 derived: net income ÷ weighted average shares · filed 2023-11-01 | -$1.47 derived: net income ÷ weighted average shares · filed 2023-11-01 | -$1.92 derived: net income ÷ weighted average shares · filed 2023-11-01 |
| 2021-12-31 | -$0.54 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$1.09 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$1.54 derived: net income ÷ weighted average shares · filed 2023-03-02 | -$1.88 10-K · filed 2023-03-02 |
| 2021-09-30 | -$0.55 10-Q · filed 2022-11-02 | -$1.00 derived: net income ÷ weighted average shares · filed 2022-11-02 | -$1.33 10-Q · filed 2022-11-02 | |
| 2021-06-30 | -$0.44 10-Q · filed 2022-08-03 | -$0.77 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | -$0.32 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |